As of January 2025, Can-Fite BioPharma has a market cap of $9.39M. This makes Can-Fite BioPharma the world's 30368th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $12.84M | 0.00% |
2023 | $12.84M | -69.05% |
2022 | $41.50M | -42.86% |
2021 | $72.62M | -26.13% |
2020 | $98.30M | -46.79% |
2019 | $184.75M | -83.89% |
2018 | $1.15B | -7.46% |
2017 | $1.24B | -45.04% |
2016 | $2.25B | -20.64% |
2015 | $2.84B | -16.76% |
2014 | $3.41B | -30.85% |
2013 | $4.93B | 20.00% |
2012 | $4.11B | -25.67% |
2011 | $5.53B | -39.62% |
2010 | $9.16B | 17.78% |
2009 | $7.78B | 145.14% |
2008 | $3.17B | -63.29% |
2007 | $8.64B | -38.70% |
2006 | $14.10B | -15.78% |
2005 | $16.75B | - |